Literature DB >> 19262472

A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell.

Daisuke Nagata1, Arihiro Kiyosue, Masao Takahashi, Hiroshi Satonaka, Kimie Tanaka, Masataka Sata, Tetsuo Nagano, Ryozo Nagai, Yasunobu Hirata.   

Abstract

The inhibition of apoptotic changes in vascular endothelial cells is important for preventing vascular damage from hypoxia. AMP-activated protein kinase (AMPK) has recently been identified as playing a role in vascular protection. Although the chemical reagent 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR) has been used to stimulate AMPK activity, AICAR has been associated with several nonspecific reactions. We therefore constructed a new constitutively active mutant of AMPK alpha 1 (NcaAMPK), which lacks the autoinhibitory domain in AMPK alpha 1 and in which threonine 172 has been replaced with aspartate. We investigated whether NcaAMPK has an anti-apoptotic effect in vascular endothelial cells under anoxic conditions. NcaAMPK, or green fluorescent protein (GFP) as a control, was overexpressed in human umbilical vein endothelial cells (HUVECs). After HUVECs were incubated for 40 h under normoxic or anoxic conditions, we examined cell viability, caspase 3/7 activity, and expression and phosphorylation levels of apoptosis-related proteins. Cell viabilities under anoxic conditions were improved in NcaAMPK-overexpressing cells. Anoxia increased caspase 3/7 activity, but NcaAMPK reduced this increase significantly. NcaAMPK overexpression increased protein kinase B/Akt Ser473 and endothelial nitric oxide synthase Ser1177 phosphorylation, but pretreatment with the nitric oxide synthase inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) did not decrease the viability of NcaAMPK-overexpressing HUVECs. Furthermore, co-expression of a dominant-negative Akt reduced the improvement in cell viability and the suppression of poly (ADP-ribose) polymerase cleavage by NcaAMPK under anoxic conditions. In conclusion, NcaAMPK inhibited anoxia-induced apoptosis in vascular endothelial cells through Akt activation, suggesting that activation of AMPK might protect against ischemic vascular injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19262472     DOI: 10.1038/hr.2008.25

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  14 in total

1.  Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival.

Authors:  Xiao-ming Liu; Kelly J Peyton; Ahmad R Shebib; Hong Wang; Ronald J Korthuis; William Durante
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

2.  Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.

Authors:  Xiaoying Huang; Rong Fan; Yuanyuan Lu; Chang Yu; Xiaomei Xu; Xie Zhang; Panpan Liu; Shuangquan Yan; Chun Chen; Liangxing Wang
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

3.  Activation of AMP-activated protein kinase alpha1 alleviates endothelial cell apoptosis by increasing the expression of anti-apoptotic proteins Bcl-2 and survivin.

Authors:  Chao Liu; Bin Liang; Qilong Wang; Jiliang Wu; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

4.  Shear stress-induced mitochondrial biogenesis decreases the release of microparticles from endothelial cells.

Authors:  Ji-Seok Kim; Boa Kim; Hojun Lee; Sunny Thakkar; Dianne M Babbitt; Satoru Eguchi; Michael D Brown; Joon-Young Park
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-05-29       Impact factor: 4.733

5.  Altered metabolism and persistent starvation behaviors caused by reduced AMPK function in Drosophila.

Authors:  Erik C Johnson; Nevzat Kazgan; Colin A Bretz; Lawrence J Forsberg; Clare E Hector; Ryan J Worthen; Rob Onyenwoke; Jay E Brenman
Journal:  PLoS One       Date:  2010-09-20       Impact factor: 3.240

6.  Glucose regulates MafA transcription factor abundance and insulin gene expression by inhibiting AMP-activated protein kinase in pancreatic β-cells.

Authors:  Ryo Iwaoka; Kohsuke Kataoka
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

Review 7.  AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases.

Authors:  Rai Ajit K Srivastava; Stephen L Pinkosky; Sergey Filippov; Jeffrey C Hanselman; Clay T Cramer; Roger S Newton
Journal:  J Lipid Res       Date:  2012-07-13       Impact factor: 5.922

8.  Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury: possible mechanisms.

Authors:  Susagna Padrissa-Altés; Mohamed Amine Zaouali; Ramon Bartrons; Joan Roselló-Catafau
Journal:  Clin Sci (Lond)       Date:  2012-07       Impact factor: 6.124

9.  NQO1-induced activation of AMPK contributes to cancer cell death by oxygen-glucose deprivation.

Authors:  Hyemi Lee; Eun-Taex Oh; Bo-Hwa Choi; Moon-Taek Park; Ja-Kyeong Lee; Jae-Seon Lee; Heon Joo Park
Journal:  Sci Rep       Date:  2015-01-14       Impact factor: 4.379

10.  Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells.

Authors:  Masahiro Myojo; Daisuke Nagata; Daishi Fujita; Arihiro Kiyosue; Masao Takahashi; Hiroshi Satonaka; Yoshiyuki Morishita; Tetsu Akimoto; Ryozo Nagai; Issei Komuro; Yasunobu Hirata
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.